Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/12/2025

Unilateral Hydronephrosis in Third Trimester Fetal Ultrasound

Clinical Significance and Risk Stratification

  • The American College of Obstetricians and Gynecologists recommends that unilateral hydronephrosis detected in the third trimester is most commonly a benign, transient finding that resolves spontaneously in approximately 80% of cases, but requires postnatal follow-up ultrasound to exclude pathologic obstruction, particularly when the anteroposterior diameter (APD) exceeds 7 mm 1
  • An APD of less than 7 mm in the third trimester represents normal physiologic variation and requires only a single follow-up ultrasound at ≥32 weeks of gestation, according to the American College of Obstetricians and Gynecologists 1
  • Approximately 80% of cases with APD between 4-7 mm in the second trimester resolve completely without intervention, as stated by the American College of Obstetricians and Gynecologists 1
  • Isolated mild hydronephrosis carries minimal risk for aneuploidy, with a positive likelihood ratio of only 1.5 for trisomy 21, according to the American College of Obstetricians and Gynecologists 1
  • The presence of calyceal dilation, abnormal parenchymal thickness or appearance, ureteral dilation, bladder abnormalities, or oligohydramnios elevates the classification to UTD A2-3, indicating increased risk, as stated by the American College of Obstetricians and Gynecologists 1

Antenatal Management Algorithm

  • For isolated UTD A1 (APD <7 mm, no other abnormalities), the American College of Obstetricians and Gynecologists recommends performing a single follow-up ultrasound at ≥32 weeks of gestation to reassess 1
  • No aneuploidy screening is required if prior screening was negative or low-risk, according to the American College of Obstetricians and Gynecologists 1
  • If no prior aneuploidy screening was performed, the American College of Obstetricians and Gynecologists recommends counseling regarding the minimal increased risk (LR 1.5) and offering noninvasive screening with cell-free DNA or quad screen 1
  • For UTD A2-3 or APD ≥7 mm, the American College of Obstetricians and Gynecologists recommends performing a comprehensive assessment including evaluation of calyceal dilation, parenchymal thickness, ureteral dilation, bladder morphology, and amniotic fluid volume 1
  • The American College of Obstetricians and Gynecologists also recommends assessing for associated structural abnormalities, particularly cardiovascular and renal anomalies, as these increase aneuploidy risk from 4% to 50% 1